Breaking Today

Merck CEO Announces Structure and Global Leadership Team for New Merck
Business Wire

CRESTOR(R) Reduced Risk of Cardiovascular Events in Elderly Patients in New Analysis of Jupiter
PR Newswire

POZEN Announces FDA Acceptance of NDA For VIMOVO
Business Wire

The Medicines Company Announces New Publication of Data Showing Angiomax(R) Reduces Cardiac Mortality and Improves Overall Survival
Marketwire

FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
PR Newswire